The Irish building materials firm claims it paid $9m “in excess” tariffs after the US Supreme Court struck down Donald Trump’s banner trade policy. It is taking legal action to claim the sum back.
The controversial Mercosur trade deal now applies provisionally and has caused fierce splits but Irish MEPs are finding more common ground on new deals with India and Australia.
Drugmakers or nations that strike pricing deals or make U.S. manufacturing investment commitments can secure lower levies, or be spared them entirely, write Gavin Bade and Xavier Martinez, The Wall Street Journal.
The US Supreme Court ruling is a constitutional landmark, but it does little to settle the deeper shift toward protectionism. For Europe — and especially Ireland’s pharma-driven economy — the outlook is increasingly fragile.
Ruling finds U.S. president exceeded his powers by imposing duties without clear authorization from Congress, write James Romoser and Gavin Bade, The Wall Street Journal.
President Trump has pressured trading partners for investment in U.S. manufacturing plants. What if local industries can’t compete? Writes Gavin Bade, The Wall Street Journal.
Ireland’s critique of the EU-Mercosur trade deal is causing increasing frustration in Brussels but MEPs are taking their time to pore over the fine print on new safeguards for farmers.
Trade turbulence has cast a shadow over doing business in the US. Irish firms are ploughing ahead with investments there but the playbook has got a little complicated.
The UK has set about vastly improving the safety of young people online with legislation that places age checks on pornographic and harmful content. It's facing significant criticism from the privacy campaigners as well as American free-speech absolutionists.
The company’s total funding now stands at $68m. It is planning to roll out an expanded AI-based product for manufacturers to manage their businesses.
© 2026 Currency Media Limited
